Impact of Telomere Biology and Sperm DNA Fragmentation on Embryonic Development
NCT ID: NCT05508217
Last Updated: 2024-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
204 participants
OBSERVATIONAL
2022-08-22
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Finally, the correlations between age, normality or not of the seminogram, LT, Short telomers (ST) accumulation, DNA fragmentation levels, sperm maturation and fertility, blastocyst development, and pregnancy rates will be established in search of cut-off points that can give a forecast of man´s fertility who consults on this subject.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of ICSI Outcomes in Cycles Using Testicular and Ejaculate Sperm From Couples With High SDF
NCT04795440
Study of Sperm Molecular Factors Implicated in Male Fertility
NCT00481403
Study of the ZyMōt Sperm Selection Method and Its Effect on Embryo Ploidy.
NCT06384794
sperDNA Fragmentation a a Predictor for Outcome After Varicocelectomy,m
NCT07144891
Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions
NCT02527954
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Males with any known chronic disease or genetic alteration.
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IVI Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Balmori Boticario, PhD
Role: PRINCIPAL_INVESTIGATOR
IVI Madrid
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ivirma Madrid
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
CARLOS BALMORI, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2202-MAD-024-CB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.